(VIANEWS) - LG Display Co, Ltd AMERICAN (LPL), Brunswick Corporation (BC), KKR & Co. (KKR) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. LG Display Co, Ltd AMERICAN (LPL)
33.1% sales growth and 3.05% return on equity
LG Display Co., Ltd.
LG Display Co, Ltd AMERICAN's sales growth this year is anticipated to be 36.8% and 0.6% for next year.
Year-on-year quarterly revenue growth grew by 45.7%, now sitting on 26.39T for the twelve trailing months.
Volume
Today's last reported volume for LG Display Co, Ltd AMERICAN is 342337 which is 42.45% below its average volume of 594879.
LG Display Co, Ltd AMERICAN's sales growth for the next quarter is 33.1%. The company's growth estimates for the current quarter and the next is 178.6% and 1250%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.05%.
Volatility
LG Display Co, Ltd AMERICAN's last day, last week, and last month's current volatility was 0.10%, 1.06%, and 1.37%, respectively.
LG Display Co, Ltd AMERICAN's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.23% (day), 1.50% (last week), and 1.35% (last month), respectively.
LG Display Co, Ltd AMERICAN's Stock Yearly Top and Bottom Value
LG Display Co, Ltd AMERICAN's stock is valued at $9.76 at 11:22 EST, way under its 52-week high of $12.31 and way above its 52-week low of $5.07.
LG Display Co, Ltd AMERICAN's Moving Average
LG Display Co, Ltd AMERICAN's worth is under its 50-day moving average of $10.37 and under its 200-day moving average of $10.31.2. Brunswick Corporation (BC)
28.2% sales growth and 32.13% return on equity
Brunswick Corporation designs, manufactures, and markets recreation products worldwide.
Brunswick Corporation's sales growth this year is expected to be 28.5% and 6.7% for next year.
Year-on-year quarterly revenue growth grew by 48.4%, now sitting on 4.82B for the twelve trailing months.
Volume
Today's last reported volume for Brunswick Corporation is 657889 which is 1.21% below its average volume of 665924.
Brunswick Corporation's sales growth for the next quarter is 28.2%. The company's growth estimates for the ongoing quarter and the next is 116.2% and 7.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 32.13%.
Volatility
Brunswick Corporation's last day, last week, and last month's current volatility was 0.10%, 1.08%, and 1.42%, respectively.
Brunswick Corporation's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.68% (day), 2.45% (last week), and 2.81% (last month), respectively.
Brunswick Corporation's Stock Yearly Top and Bottom Value
Brunswick Corporation's stock is valued at $97.43 at 11:22 EST, way under its 52-week high of $117.62 and way above its 52-week low of $56.50.
Brunswick Corporation's Moving Average
Brunswick Corporation's value is above its 50-day moving average of $97.13 and below its 200-day moving average of $97.56.3. KKR & Co. (KKR)
19.1% sales growth and 36.38% return on equity
KKR & Co.'s sales growth this year is anticipated to be 30.6% and 15.3% for next year.
Year-on-year quarterly revenue growth declined by 0%, now sitting on 20.64B for the twelve trailing months.
Volume
Today's last reported volume for KKR & Co. is 1374700 which is 44.84% below its average volume of 2492210.
KKR & Co.'s sales growth for the next quarter is 19.1%. The company's growth estimates for the present quarter and the next is 100% and 56.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 36.38%.
Volatility
KKR & Co.'s last day, last week, and last month's current volatility was 0.19%, 1.02%, and 1.17%, respectively.
KKR & Co.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.67% (day), 2.26% (last week), and 1.93% (last month), respectively.
KKR & Co.'s Stock Yearly Top and Bottom Value
KKR & Co.'s stock is valued at $62.45 at 11:22 EST, under its 52-week high of $63.67 and way above its 52-week low of $32.73.
KKR & Co.'s Moving Average
KKR & Co.'s value is higher than its 50-day moving average of $58.48 and way higher than its 200-day moving average of $51.67.Previous days news about KKR & Co.(KKR)
According to Bloomberg Quint on Tuesday, 27 July, "Spark Infrastructure Group said it would engage with Ontario Teachers' Pension Plan Board and KKR & Co. over a takeover after the partners made an improved bid."
4. MagnaChip Semiconductor Corporation (MX)
17.1% sales growth and 40.41% return on equity
MagnaChip Semiconductor Corporation, together with its subsidiaries, designs, manufactures, and sells analog and mixed-signal semiconductor platform solutions for communications, Internet of Things, consumer, industrial, and automotive applications.
MagnaChip Semiconductor Corporation's sales growth this year is expected to be 5.7% and 8.4% for next year.
Year-on-year quarterly revenue growth grew by 2.1%, now sitting on 509.6M for the twelve trailing months.
Volume
Today's last reported volume for MagnaChip Semiconductor Corporation is 163793 which is 79.23% below its average volume of 788476.
MagnaChip Semiconductor Corporation's sales growth is a negative 0% for the ongoing quarter and 17.1% for the next. The company's growth estimates for the current quarter and the next is 53.8% and 92.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 40.41%.
Volatility
MagnaChip Semiconductor Corporation's last day, last week, and last month's current volatility was 0.85%, 1.74%, and 0.94%, respectively.
MagnaChip Semiconductor Corporation's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.46% (day), 2.46% (last week), and 2.02% (last month), respectively.
MagnaChip Semiconductor Corporation's Stock Yearly Top and Bottom Value
MagnaChip Semiconductor Corporation's stock is valued at $22.48 at 11:22 EST, way under its 52-week high of $26.98 and way higher than its 52-week low of $10.50.
MagnaChip Semiconductor Corporation's Moving Average
MagnaChip Semiconductor Corporation's worth is under its 50-day moving average of $23.64 and above its 200-day moving average of $22.35.5. Park City Group (PCYG)
16.5% sales growth and 7.88% return on equity
Park City Group, Inc., a software-as-a-service provider, designs, develops, and markets proprietary software products in North America and internationally.
Park City Group's sales growth this year is expected to be 11.2% and 11% for next year.
Year-on-year quarterly revenue growth grew by 30%, now sitting on 22.19M for the twelve trailing months.
Volume
Today's last reported volume for Park City Group is 23489 which is 76.39% below its average volume of 99487.
Park City Group's sales growth for the next quarter is 16.5%. The company's growth estimates for the present quarter and the next is 100% and 33.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.88%.
Volatility
Park City Group's last day, last week, and last month's current volatility was 2.49%, 1.75%, and 1.58%, respectively.
Park City Group's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.36% (day), 3.59% (last week), and 4.59% (last month), respectively.
Park City Group's Stock Yearly Top and Bottom Value
Park City Group's stock is valued at $5.60 at 11:22 EST, way under its 52-week high of $7.91 and way above its 52-week low of $3.80.
Park City Group's Moving Average
Park City Group's worth is below its 50-day moving average of $5.64 and below its 200-day moving average of $5.92.6. Alexion Pharmaceuticals (ALXN)
7.4% sales growth and 4.43% return on equity
Alexion Pharmaceuticals, Inc. develops and commercializes various therapeutic products.
Alexion Pharmaceuticals's sales growth this year is anticipated to be 10.6% and 7% for next year.
Year-on-year quarterly revenue growth grew by 13.3%, now sitting on 6.26B for the twelve trailing months.
Volume
Today's last reported volume for Alexion Pharmaceuticals is 80855000 which is 2965.1% above its average volume of 2637920.
News about Alexion Pharmaceuticals(ALXN) today
According to today's article on Bloomberg Quint, "Astra expects core earnings of $5.05 to $5.40 per share following the acquisition of rare-disease specialist Alexion Pharmaceuticals Inc. Astra previously estimated earnings of $4.75 to $5 a share. "
Alexion Pharmaceuticals's sales growth for the next quarter is 7.4%. The company's growth estimates for the ongoing quarter and the next is 7.1% and 4.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.43%.
Alexion Pharmaceuticals's Stock Yearly Top and Bottom Value
Alexion Pharmaceuticals's stock is valued at $182.50 at 11:22 EST, under its 52-week high of $187.45 and way higher than its 52-week low of $99.91.
Alexion Pharmaceuticals's Moving Average
Alexion Pharmaceuticals's value is higher than its 50-day moving average of $181.43 and way higher than its 200-day moving average of $165.02.7. Manhattan Associates (MANH)
7.3% sales growth and 52.86% return on equity
Manhattan Associates, Inc. develops, sells, deploys, services, and maintains software solutions to manage supply chains, inventory, and omni-channel operations for retailers, wholesalers, manufacturers, logistics providers, and other organizations.
Manhattan Associates's sales growth this year is expected to be 8.1% and 8.8% for next year.
Year-on-year quarterly revenue growth grew by 1.9%, now sitting on 589.32M for the twelve trailing months.
Volume
Today's last reported volume for Manhattan Associates is 53660 which is 85.21% below its average volume of 362712.
Manhattan Associates's sales growth for the next quarter is 7.3%. The company's growth estimates for the ongoing quarter and the next is 7.5% and negative -17.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 52.86%.
Volatility
Manhattan Associates's last day, last week, and last month's current volatility was 1.91%, 1.31%, and 1.07%, respectively.
Manhattan Associates's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.42% (day), 2.39% (last week), and 2.21% (last month), respectively.
Manhattan Associates's Stock Yearly Top and Bottom Value
Manhattan Associates's stock is valued at $147.66 at 11:22 EST, under its 52-week high of $149.78 and way above its 52-week low of $83.74.
Manhattan Associates's Moving Average
Manhattan Associates's worth is above its 50-day moving average of $143.66 and way above its 200-day moving average of $129.76.8. Globus Medical (GMED)
5.4% sales growth and 7.03% return on equity
Globus Medical, Inc., a medical device company, focuses on the development and commercialization of implants that heal patients with musculoskeletal disorders.
Globus Medical's sales growth this year is anticipated to be 17.5% and 10.1% for next year.
Year-on-year quarterly revenue growth grew by 10.3%, now sitting on 789.04M for the twelve trailing months.
Volume
Today's last reported volume for Globus Medical is 327556 which is 26.1% below its average volume of 443255.
Globus Medical's sales growth for the next quarter is 5.4%. The company's growth estimates for the ongoing quarter and the next is 528.6% and negative -8.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.03%.
Volatility
Globus Medical's last day, last week, and last month's current volatility was 2.19%, 1.69%, and 1.40%, respectively.
Globus Medical's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.07% (day), 1.99% (last week), and 2.13% (last month), respectively.
Globus Medical's Stock Yearly Top and Bottom Value
Globus Medical's stock is valued at $83.04 at 11:22 EST, below its 52-week high of $83.18 and way above its 52-week low of $47.34.